MediVet Biologics announces an exciting speaking engagement at the Western Veterinary Conference (WVC) lead by …

Nicholasville, Kentucky (PRWEB) January 28, 2015

Cancer Vaccines are few and far between, especially when dealing with canine cancers. In fact, there are only a few viable treatment options available to our beloved pets. MediVet Biologics, a leading provider of in-clinic regenerative medicine services is pleased to announce, K9-ACV a canine cancer vaccine and service applicable to the general practice!

This novel technology has generated excitement and many inquiries since the announcement of its development in early 2015. MediVet Biologics will be hosting a lunch and learn at the Western Vet Conference (WVC) on Tuesday February 17th from Noon to 2PM (PST). The two inventors and industry opinion leaders, Drs. John Yanelli and Don Cohen from the University of Kentucky College of Medicine will be presenting the technology protocols and answering questions.

Also, the progressive conversation continues as Dr. Mike Hutchinson, the Worlds leading Veterinary Regenerative Medicine practitioner, will also be sharing some exciting developments in the field of regenerative medicine. With his 850 stem cell therapy procedures, Dr. Mike has seen it all but he continues to be impressed at the life changing effects stem cell therapy has on his patients.

Please join MediVet Biologics on Tuesday, February 17th from Noon to 2PM (PST) in the Palo Verde room at the Four Seasons for this exciting opportunity to learn about cutting edge technologies!

Space is at a premium and very limited, be sure to pre-register to ensure a seat. All pre-registrants receive a free Cancer Service ($750 value) and are entered to win one of two valuable giveaways! MediVet will be drawing for a free MediVet Stem Cell System or full tuition to the University of Tennessees Certificate program in Canine Rehabilitation (CCRP).

Register online, click here

Or

Contact: Jenny Corbin jenny(at)medivetbiologics(dot)com 859.885.7111 ext. 307

About MediVet Biologics MediVet Biologics headquartered just outside Lexington, KY and Sydney Australia is a subsidiary of Medical Australia (MLA: ASX). MediVet Biologics has global reach including established partners in 26 countries around the world as well as strong market positioning in North America. The company provides novel treatment options based in science to the Veterinary market and provides unique customer specific service plans to ensure implementation and growth of its progressive products and services.

Continued here:
MediVet Biologics announces an exciting speaking engagement at the Western Veterinary Conference (WVC) lead by ...